Basal cell carcinoma

Cancer Treatment and Research

Volumn 146, Issue , 2009, Pages 263-278

  Ferrándiz, Carlos ^a,b   Fuente, María J ^a   Ferrándiz, Lara ^c   Carrascosa, José M ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AZATHIOPRINE; CYCLOSPORIN; IMIQUIMOD; PREDNISONE; RAPAMYCIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT; RETINOID;

BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER RISK; CLINICAL FEATURE; CRYOSURGERY; GENETIC PREDISPOSITION; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; METASTASIS; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; SURGICAL APPROACH; ULTRAVIOLET RADIATION; VERRUCA VULGARIS; BIOLOGICAL MODEL; CARCINOMA, BASAL CELL; GENETICS; RISK FACTOR; SKIN NEOPLASMS; SUNLIGHT; TIME;

CARCINOMA, BASAL CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MODELS, BIOLOGICAL; MODELS, GENETIC; ORGAN TRANSPLANTATION; RETINOIDS; RISK FACTORS; SKIN NEOPLASMS; SUNLIGHT; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 76149146781     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78574-5_22     Document Type: Review

References (86)

1. Walling HW, Fosko SW, Geraminejad PA et al. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev 2004; 23:389-402
2. Johnson MJ, Johnson KJ, Engel A. Prevalence, morbidity, and cost of dermatologic diseases. J Am Acad Dermatol 1984; 11:930-6
3. Harden PN, Fryer AA, Reece S et al. Annual incidence and predicted risk of nonmelanoma skin cancer in renal transplant recipients. Transplant Proc 2001; 33:1302-4
4. Lindelöf B, Sigurgeirsson B, Gabel H et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143:513-9
5. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681-91
6. Ramsay HM, Fryer AA, Hawley CM et al. Non-melanoma skin cancer in the Queensland renal transplant population. Br J Dermatol 2002; 147:950-6
7. Kanitakis J, Alhaj-Ibrahim L, Euvrard S et al. Basal cell carcinomas developing in solid organ transplant recipients. Arch Dermatol 2003; 139:1133-7
8. Harwood CA, Proby CM, McGregor JM et al. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006; 54:290-300
9. Casson P. Basal cell carcinoma. Clin Plast Surg 1980; 7:301-11
10. Marks R. An overview of skin cancer: incidence and causation. Cancer 1995; 75:607-12
11. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998; 78:587-93
12. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30:774-8
13. Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 2003; 149:1200-6
14. Stockfleth E, Ulrich C, Meyet T et al. Skin diseases following organ transplantation: risk factors and new therapeutic approaches. Transplant Proc 2001; 33:1848-53
15. Euvrard S, Kanitakis J, Pouteil-Noble C et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33:222-9
16. Frezza EE, Fung JJ, van Thiel DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 1997; 44:1172-81
17. Jensen P, Hansen S, Moller B et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40:177-86
18. Hartevelt MM, Bavink JN, Kootte AMM et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49:506-9
19. Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154:498-504
20. Webb MC, Compton F, Andrew PA et al. Skin tumors posttransplantation. A retrospective analysis of 28 years' experience at a single center. Transplant Proc 1997; 29:828-30
21. Fuente MJ, Sabat M, Roca J et al. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149:1221-6
22. Bouwes Bavink JN, Hardie DR, Green A et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation 1996; 61:715-21
23. Fortina AB, Piaserico S, Caforio ALP et al. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004; 140:1079-85
24. Herrero JI, España A, Quiroga J et al. Nonmelanoma skin cancer after liver transplantation. Study of risk factors. Liver Transplant 2005; 11:1100-6
25. Scotto J, Kopf AW, Urbach F. Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer 1974; 34:1333-8
26. Yiannias JA, Goldberg LH, Carter-Campebell S et al. The ratio of basal cell carcinoma to squamous cell carcinoma in Houston, Texas. J Dermatol Surg Oncol 1988; 14:886-9
27. Marks R, Jolley D, Dorevitch et al. The incidence of non-melanocytic skin cancer in an Australian population. Results of a five years prospective study. Med J Aust 1989; 150:475-8
28. Lampros TD, Cobanoglu A, Parker F et al. Squamous and basal cell carcinoma in heart transplant recipients. J Heart Lung Transplant 1998; 17:586-91
29. Ong CS, Keogh Am, Kossard S et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40;27-34
30. España A, Martinez-Gonzalez MA, Garcia-Granero M et al. A prospective study of incidence nonmelanoma skin cancer in heart transplant recipients. J Invest Dermatol 2000; 115;1158-60
31. Ulrich C, Schmook T, Sachse M et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004; 30:622-7
32. Naldi L, Fortina AB, Lovati S. Risk of nonmelanoma skin cancer in Italian organ transplant recipients: a registry based study. Transplantation 2000; 70:1479-84
33. Ferrándiz C, Fuente MJ, Ribera M et al. Epidermal dysplasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol 1995; 33:590-6
34. Levy M, Backman L, Husberg B et al. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 1993; 25:1397-9
35. Caforio AL, Fortina AB, Piaserico S et al. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000; 102(suppl 3):222-27
36. España A, Redondo P, Fernández AL, et al. Skin cancer in heart transplant recipients. J Am Acad Dermatol 1995; 32:458-65
37. Euvrard S, Kanitakis J, Cochat P et al. Skin cancers following organ transplantation. Dermatol Surg 2004; 30:616-21
38. Menni S, Beretta D, Piccino R et al. Cutaneous and oral lesions in 32 children after renal transplantation. Pediatr Dermatol 1991; 8:194-8
39. Halper E, Tunnessen WW, Fivush B et al. Cutaneous lesions associated with cyclosporine therapy in pediatric renal transplant recipients. J Pediatr 1991; 119:489-91
40. Euvrard S, Kanitakis J, Cochat P et al. Skin diseases in children with organ transplants. J Am Acad Dermatol 2001; 44:932-9
41. Rubin A, Chen AH, Ratner D. Basal cell carcinoma. N Engl J Med 2005; 353:2262-9
42. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990; 23:1118-26
43. Habets JMW, Tank B, Vuzevski VD. Characterization of the mononuclear cell infiltrate in basal cell carcinoma: a predominantly T cell-mediated immune response with minor participation of Leu-7+ (natural killer) cells and Leu-14+ (B) cells. J Invest Dermatol 1988; 90:289-292.
44. Batra RS, Kelley LC. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol 2002; 138:1043-51
45. Parnes R, Safai B, Myskowski PL. Basal cell carcinoma and lymphoma: biological behavior and associated factors in sixty-three patients. J Am Acad Dermatol 1988; 19:1017-23
46. Smith KJ, Skelton HG, Yeager J et al. Cutaneous neoplasms in a military population of HIV-1 patients. J Am Acad Dermatol 1993; 29:400-6
47. Oram Y, Orengo I, Griego RD et al. Histologic patterns of basal cell carcinoma based upon patient immunostatus. Dermatol Surg 1995; 21:611-4
48. Bastiaens MT, Hoefnagel JJ, Bruijn JA et al. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinomas indicate different types of tumours. J Invest Dermatol 1998; 110:880-4
49. Raasch BA, Buettner PG, Garbe C. Basal cell carcinoma: histological classification and bodysite distribution. Br J Dermatol 2006; 155:401-7
50. Lefell DJ, Headington JT, Wong D et al. Aggressive growth basal cell carcinoma in young adults. Arch Dermatol 1991; 127:1663-7
51. Corona R, Dogliotti E, D'Errico M et al. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol 2001; 137:116-8
52. Kricker A, Armstrong BK, English DR et al. Does intermittent exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer 1995; 60:489-94
53. Ramsay HM, Fryer AA, Hawley CM et al. Factors associated with non-melanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003; 49:397-406
54. Bouwes Bavink JN, Kootte Am, Van der Woude FJ et al. HLA-A11-associated resistance to skin cancer in renal transplant recipients. N Engl J Med 1990; 323:1350
55. Bouwes Bavink JN, Claas FHJ, Hardie DR et al. Relation between HA antigens and skin cancer in renal transplant recipients in Queensland. Aust J Invest Dermatol 1997; 108:708-11
56. McGregor JM, Reddi G, NacDonald D et al. HLA-A11 in renal allograft recipients with skin cancer. J Invest Dermatol 1991; 98:261-2
57. Czarnecki D, Watkins F, Leahy S et al. Skin cancer and HLA frequencies in renal transplant recipients. Dermatology 1992; 185:9-11
58. Rompel R, Petres J, Kaupert K et al. HLA phenotype and multiple basal cell carcinomas. Dermatology 1994; 189:222-4
59. Zanetti R, Rosso S, Martinez C et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. Br J Cancer 2006; 94:743-51
60. Lear JT, Tan BB, Smith AG et al. Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med 1997; 90:371-4.
61. Vitasa BC, Taylor HR, Strickland PT et al. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 1990; 65:2811-7
62. Caroll RP, Ramsay HM, Fryer AA et al. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation. A prospective study in Qeensland, Australia. Am J Kidney Dis 2003; 41:676-83
63. Dantal J, Hourmant N, Cantarovih D et al. Long term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporine regimens. Lancet 1998; 351:623-28
64. Ducloux D, Carron PL, Rebibou JM et al. CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation 1998; 65:1270-2.
65. Jemec GB, Holm EA. Nonmelanoma skin cancer in organ transplant recipients. Transplantation 2003; 75:253-7
66. GloverMT, Deeks JJ, Raftery MJ et al. Immunosuppression and the risk of nonmelanoma skin cancer in renal transplant recipients. Lancet 1997; 349:398
67. Marcen R, Pascual J Tato AM et al. Influence of immunosuppression on the prevalence of cancer after kidney transplantation. Transplant Proc 2003; 35:1714-6
68. Mithoefer AB, Supran S, Freeman RB. Risk factors associated with the development of skin cancer after liver transplantation. Liver Transplant 2002; 8:939-44
69. Campistol JM, Eris J, Oberbauer R et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006; 17:581-9
70. Mathew T, Kreis H, Friend P. Two year incidence of malignancy in sirolimus treated renal transplant recipients: results from five multicenter studies. Clin Transplant 2004; 18:446-9
71. Euvrard S, Chardonnet Y, Pouteil-Noble C et al. Association of skin malignancies with various and multiple carcinogenic and non-carcinogenic human papillomavirus in renal transplant recipients. Cancer 1993; 72:2198-206
72. Lindelöf B, Granath F, Dal H et al. Sun habits in kidney transplant recipients with skin cancer: a case control study of possible causative factors. Acta Dermatol Venerol 2003; 83:189-93
73. Harwood CA, Surentheran T, McGregor JM et al. Human papillomavirus infection and nonmelanoma skin cancer in immunosuppressed and immunocompetent individuals, J Virol 2000; 61:289-97
74. Berkhout R, Bouwes-Bavink JN, ter Scchegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38:2087-96
75. Wieland U, Ritzkowsky A, Stoltidis M et al. Papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association? J Invest Dermatol 2000; 115:124-8
76. Stockfleth E, Nindl I, Sterry W et al. Human papilloma viruses in transplant-associated skin cancers. Dermatol Surg 2004; 30:4:604-9
77. Shamanin V, Zur Hausen H, Lavergne D et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996; 88:802-11
78. Karagas MR, Nelson HH, Sehr P et al. Human papillomavirus infection and incidence of squamous and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98:389-95
79. Telfer NR, Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. Br J Dermatol 1999; 141:415-23
80. Rowe DE. Comparison of treatment modalities for basal cell carcinoma. Clin Dermatol 1995; 13:617-20
81. Silverman MK, Kopf AV, Grin CM, Bart RS, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 2: Curretage-electrodessication. J Dermatol Surg Oncol 1991; 17:720-6
82. Kuflik EG, Gage A. The five-year cure rate achieved by cryosurgery for akin cancer. J Am Acad Dermatol 1991; 24:1002-4
83. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE et al. 5-Aminolevulinic acid-based photodynamic therapy. Cancer 1997; 79:2282-308
84. Marks R, Gebauer K, Shumak S, Amies M, Bryden J, Fox TL et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicentre 6 week dose-response trial. J Am Acad Dermatol 2001; 44:807-13
85. Stockfleth E, Ulrich C, Meyer T, Christophers E. Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res 2002;160:251-8
86. De Graaf YGL, Euvrard S, Bouwes Bvinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg 2004; 30:656-61